Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
2.75 Fte (5)
Lobbyists with EP accreditation
1
High-level Commission meetings
5
Lobbying Costs over the years
-
Info
Stichting Health Action International (HAI)
EU Transparency Register
44361352681-84 First registered on 30 Nov 2009
Goals / Remit
Health Action International is a non-profit, independent global network of consumer groups, public interest NGOs, healthcare professionals, academics, and individuals working and interested on pharmaceutical policy issues. HAI’s mission is to increase access to essential medicines and improve their rational use through research excellence and evidence-based advocacy.
In Europe, HAI has grown to become a pre-eminent voice in medicines policy intervention/discussion, supported by a strong European network of approximately >125 individual and organisation members from 19 European Union (EU) Member States and 14 other non-EU countries. The HAI Europe projects team, based in Amsterdam, is responsible for coordinating the work programme and related activities within the European region. HAI monitors and advocates on EU policies that affect medicines on three key thematic priorities: Access to Needed Medicines, the Rational Use of Medicines, and the Democratisation of Medicines Policy.Main EU files targeted
HAI advocates for policy initiatives that help to address current shortfalls/shortcomings on access to medicines. In Europe, HAI monitors EU policy initiatives and developments with an impact on access to medicines, their rational use and on the democratisation of medicines policy. Where needed, we issue recommendations for improvement on specific topics. EU legislation, policies and initiatives of particular interest include: implementation of proposals on EU cooperation on Health Technology Assessment and clinical trials regulation; discussion of European Pharmaceutical Strategy and review of EU pharmaceutical legislation, and orphan designation and other IP incentives; EU IP Action Plan and enforcement strategy, including revision of Supplementary Protection Certificate Regulation; Competition policy; EU trade agreements with impact on access to medicines; Innovative Medicines Initiative and Horizon Europe; Multiannual Financial Framework (MFF); implementation of the One Health Action Plan against AMR; European Medicine Agency (EMA)'s policies and activities; tackling medicines shortages. HAI also advocates for stricter regulations on pharmaceutical promotion in Europe especially among healthcare professionals and students.
In response to the Covid-19 crisis HAI has been advocating for timely access to affordable vaccines, therapeutics and diagnostics across the EU, transparency in negotiations between governments, the European Commission and pharmaceutical companies, and has been working to support the consolidation and use of the WHO Covid-19 Technologies Access Pool (C-TAP). We expect this work to continue during 2022.Address
Head Office
Overtoom, 60/II
Amsterdam 1054HK
NETHERLANDSEU Office
Overtoom, 60/II
Amsterdam 1054HK
NETHERLANDSWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 100% 1 75% 1 50% 1 25% 2 Lobbyists (Full time equivalent)
2.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 13 May 2022
Name Start date End Date Ms Hannah VAN KOLFSCHOOTEN 14 Dec 2022 14 Dec 2023 Ms Janneke VAN OIRSCHOT 09 Dec 2022 09 Dec 2023 Mr Jaume VIDAL 04 Nov 2022 04 Nov 2023 Ms Ellie WHITE 27 Oct 2021 11 Feb 2022 Mr Jaume VIDAL 27 Oct 2021 27 Oct 2022 Mr Jaume VIDAL 19 Sep 2019 19 Sep 2020 Ms Ellie WHITE 14 Sep 2019 12 Sep 2020 Ms Ancel·la Santos Quintano 13 Oct 2018 25 Apr 2019 Mr Jaume VIDAL 13 Oct 2018 19 Sep 2019 Ms Ancel·la Santos Quintano 14 Oct 2017 13 Oct 2018 Mr Jaume VIDAL 20 Jul 2017 07 Jul 2018 Ms Tessel Mellema 07 Sep 2016 21 Jul 2017 Ms Ancel·la Santos Quintano 07 Sep 2016 07 Sep 2017 Ms Tessel Mellema 27 Aug 2015 26 Aug 2016 Ms Ancel·la Santos Quintano 27 Aug 2015 26 Aug 2016 Ms Aliénor Devalière 27 Aug 2015 23 Jun 2016 Ms Ancel·la Santos Quintano 01 May 2014 05 Jun 2015 Ms Aliénor Devalière 07 Jun 2014 05 Jun 2015 Mrs Aliénor Devalière 07 Jun 2014 27 Jan 2015 Ms Tessel Mellema 01 May 2014 05 Jun 2015 Mrs Ancel·la Santos Quintano 01 May 2014 27 Jan 2015 Ms Tessel Mellema 25 Jun 2013 01 May 2014 Mrs Ancel·la Santos Quintano 30 May 2013 01 May 2014 Ms Katrina Perehudoff 22 Sep 2012 17 Jun 2013 Ms Tessel Mellema 20 Sep 2012 25 Jun 2013 Complementary Information
HAI has one full-time policy advisor that is solely focused on our EU projects. He is supported by Admin, Communications, PME & our Executive Director.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
HAI is a member of the European Public Health Alliance (EPHA), the International Society of Drug Bulletins (ISDB), the Transatlantic Consumer Dialogue (TACD), the Medicines in Europe Forum (MiEF), the European Alliance for Responsible R&D and Affordable Medicines, the Antimicrobial Resistance Coalition, and Global Snakebite Initiative. In addition, HAI enters into strategic partnership with other associations when collaborating on certain topics thus tapping into extended expertise as required.
HAI is also a member of the EMA’s Patients and Consumers Working Party (PCWP), the HTA Network Stakeholder Pool and co-chair of European Parliament Working Group on Access to Medicines.
HAI is in official relations with the WHO and collaborates with the organisation on several projects as well as attending governing bodies and ad-hoc meetingsMember organisations
Member organisations:
BUKO Pharma-Kampagne
Public Eye
La Revue Prescrire
Medico International
Medicus Mundi Switzerland
Mezis
Physicians for Social Responsibility
Oxfam GB
Salud por Derecho
Wemos
T1 International
Health Projects for Latvia
EKPIZO
UAEM
Partnership for Global Health / plan:g
The Independent Diabetes Trust (IDDT)
VdPP (Association of Democratic Pharmacists) -
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
1,946,396€
Major funding types in closed year
Public financing, EU funding, Member's contribution, Grants
Major contributions in closed year
Type Name Amount Contribution Helmsley Charitable Trust 930,712€ Contribution European Commission/HADEA 213,692€ Grant European Commission/HADEA 213,692€ Other financial info
N/A
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Artificial intelligence and digital
Communication activities
For our publications please visit: https://haiweb.org/publication/
For our press releases and other news please visit: https://haiweb.org/news/
In 2021, in relation to our European Programme, we released 26 publications and hosted several events to discuss and disseminate these. These publications, including policy briefs, formed the basis of our advocacy work. Our European work and staff were quoted in the media at least 62 times in 2021, demonstrating the added value of our published materials and that our staff are seen by media contacts as experts in their field. The European Projects Team has worked closely with the HAI Communications Team to develop engaging content that promoted our work and helped achieve project objectives. This included a number of virtual events, ranging from informative webinars to collaborative idea generation. Our European Project communications materials have garnered over 500,000 impressions across all of HAI’s digital channels.Other activities
HAI is a member of the European Medicines Agency Patients' and Consumers' Working Party (PCWP); and a member of the HTA Network Stakeholder Pool.
- Meetings
Meetings
5 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 07 Oct 2021 Location video conference Subject COVID Vaccines Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Caroline Boeshertz (Cabinet member)
Other Lobbyists -
Date 03 Jun 2021 Location video-conference Subject Trade in relation to COVID-related technologies Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Cristina Rueda Catry (Cabinet member)
- Caroline Boeshertz (Cabinet member)
Other Lobbyists -
Date 15 May 2018 Location Brussels Subject Access to medicines in poor countries Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Pedro Velasco Martins (Cabinet member)
- Maria Asenius (Cabinet member)
Other Lobbyists -
Date 15 May 2018 Location Brussels Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists - European Patients' Forum (EPF)
- ASDM Consulting
- European Public Health Alliance
- EUROPEAN ORGANISATION FOR RARE DISEASES
- European Federation of Allergy and Airways Diseases Patients' Associations
- International Diabetes Federation European Region
- Bureau Européen des Unions de Consommateurs
- European Cancer Patient Coalition
-
Date 18 Oct 2016 Location Brussels Subject Access to medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Meetings